Y, G., J, M., Z, F., Y, X., B, G., J, Y., . . . J, C. (2019). Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Gu, Ma J, Fu Z, Xu Y, Gao B, Yao J, Xu W, Chu K, y Chen J. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Dove Medical Press, 2019.
Cita MLA (8a ed.)Y, Gu, et al. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy. Dove Medical Press, 2019.
Precaución: Estas citas no son 100% exactas.